iRhythm IRTC 深 沪
等待开盘 05-26 09:30:00 美东时间
116.56
-1.310
-1.11%
华盛通- 最 高123.151
- 今 开118.09
- 成交量 46.30万股
- 最 低 112.86
- 昨 收 117.87
- 总市值 38.30亿
- 52周最高 212.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 108.81
- 委 比 42.52%
- 总股本 3286.24万
- 历史最高 286.19
- 量 比 0.85
- 振 幅 8.73%
- 历史最低 22.25
- 每 手 1
- 风险率 23.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多iRhythm Holdings to Participate in Upcoming Investor Conferences
iRhythm Holdings, Inc. will participate in the William Blair 46th Annual Growth Stock Conference on June 2, 2026, and the Truist Securities MedTech Conference on June 16, 2026. Interested parties can access live or archived webcasts via the company’s investor website. iRhythm, a leading digital health care company, creates solutions to detect, predict, and prevent diseases through wearable biosensors, cloud-based analytics, and proprietary algori...
05-19 20:05
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
B of A Securities Maintains Buy on iRhythm Holdings, Lowers Price Target to $180
B of A Securities analyst Stephanie Piazzola maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $225 to $180.
05-19 01:48
U.S. RESEARCH ROUNDUP-Exxon Mobil, Northrop Grumman, Regeneron Pharmaceuticals
U.S. RESEARCH ROUNDUP-Exxon Mobil, Northrop Grumman, Regeneron Pharmaceuticals May 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Exxon Mobil, Northrop Grumman and Regeneron Pharmaceuticals on Monday. HIGHLIGHTS * Ch
05-18 15:15
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
William Blair updates conviction stock list
William Blair updated its 2026 conviction stock list, swapping in three new names. Additions Somnigroup International Inc. (SGI): Added to the Consumer sector by analyst Phillip Blee. The rationale is...
05-04 18:37
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
iRhythm Technologies Signals Profitable Growth Amid Overhangs
Irhythm Technologies (($IRTC)) has held its Q1 earnings call. Read on for the m...
05-02 08:28
iRhythm Holdings shares are trading lower. The company reported Q1 financial results.
iRhythm Holdings shares are trading lower. The company reported Q1 financial re...
05-02 00:43
电话会总结 ｜ iRhythm(IRTC)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据iRhythm业绩会实录，以下是2026年第一季度财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 第一季度营收1.994亿美元，同比增长25.7%，主要由所有核心和新兴渠道的持续量需求驱动。 **盈利能力：** 毛利率达到70.9%，同比提升210个基点，得益于制造自动化和工作流程优化。调整后EBITDA利润率为7.1%，同比大幅改善880个基点，体现了运营杠杆和运营效率的提升。 **净亏损情况：** GAAP净亏损1,390万美元（每股亏损0.43美元），较去年同期的3,070万美元亏损（每股亏损0.97美元）显著收窄。调整后净亏
05-01 12:22
